State Street’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

State Street’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-68,247	Closed	-$5.54K	–	4917
2022 Q4	$5.54K	Hold	68,247	–	–	﹤0.01%	4829
2022 Q3	$9K	Hold	68,247	–	–	﹤0.01%	4896
2022 Q2	$19K	Hold	68,247	–	–	﹤0.01%	4882
2022 Q1	$21K	Hold	68,247	–	–	﹤0.01%	4880
2021 Q4	$157K	Buy	68,247 +57,200	+518%	+$169K	﹤0.01%	4445
2021 Q3	$26K	Buy	+11,047	New	+$41.9K	﹤0.01%	4677
2015 Q1	–	Sell	-875	Closed	-$6K	–	3696
2014 Q4	$6K	Sell	875 -90	-9%	-$704	﹤0.01%	3691
2014 Q3	$9K	Hold	965	–	–	﹤0.01%	3671
2014 Q2	$9K	Hold	965	–	–	﹤0.01%	3631
2014 Q1	$14K	Hold	965	–	–	﹤0.01%	3626
2013 Q4	$23K	Hold	965	–	–	﹤0.01%	3587
2013 Q3	$31K	Hold	965	–	–	﹤0.01%	3558
2013 Q2	$31K	Buy	+965	New	+$33.2K	﹤0.01%	3484

Other funds holding STAB

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

State Street's STAB Position: Q1 2023 in Review

State Street sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 68,247 shares — an estimated $5.54K sold.

State Street first reported a position in STAB in Q2 2013 and held it in 13 quarters. The position peaked at $157K in Q4 2021. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

State Street reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
State Street sold 68,247 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $5.54K.
State Street first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
State Street's Statera Biopharma, Inc. Common Stock position peaked at $157K in Q4 2021.
4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.